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Abstract 
 
Primary cardiac tumors are a rare entity compared to tumors that metastasize to the heart. 
Patients with such tumors may be asymptomatic. Many cases are found incidentally 
during evaluation of an unrelated medical condition. It is important for the clinician to 
have a high index of suspicion when evaluating a patient presenting with signs and 
systemic symptoms concerning for possible malignancy, plus cardiac specific symptoms 
or complications. These can include new onset dyspnea, congestive heart failure, 
arrhythmias or murmurs varying with body positions. Imaging, particularly the use of 
cardiac echocardiography, remains the cornerstone of diagnosis, and may be combined 
with new imaging modalities of cardiac CT and MRI. The aim of this paper is to describe 
the epidemiology and pathophysiology of the various benign and malignant primary 
cardiac tumors.  
 
 
Primary Cardiac Tumors  
 
 
Primary cardiac tumors are a rare entity. They have an autopsy frequency of 0.001% – 
0.28%. By contrast metastatic involvement of the heart is far more common, occurring in 
1.5% - 21% of all autopsies performed on patients (1,2,3). Approximately three-quarters 
of primary heart tumors are benign with atrial myxomas comprising three-quarters of 
those. Of the 25% of primary cardiac tumors that are malignant, approximately three-
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quarters are sarcomas (4). The aim of this paper is to describe the epidemiology, 
pathology, and pathophysiology of the various benign and malignant primary cardiac 
tumors.  
 
Presentation 
Primary cardiac tumors may be asymptomatic with up to 12% of cases found incidentally 
during evaluation of an unrelated medical condition (5). They often present in a subtle 
manner though dramatic presentations are sometimes encountered. In the case of 
malignant disease there may be direct invasion of the myocardium, causing arrhythmias 
or heart block, or pericardial effusion which may progress to life-threatening tamponade. 
They may also produce signs and symptoms of heart failure by causing progressive 
valvular regurgitation (6). Pulmonary venous hypertension secondary to physical 
obstruction of a cardiac chamber filling may result in dyspnea or frank pulmonary edema. 
Systemic emboli may occur to the brain or extremities. Constitutional symptoms, such as 
fevers and arthralgias, can sometimes be present (7). Interestingly, body position may 
influence the severity of symptoms due to the movement of tumor within the heart, and a 
characteristic early diastolic “tumor plop” may be heard on auscultation.   
 
Benign Cardiac Tumors 
Atrial Myxomas 
Atrial myxomas are the most common primary cardiac tumors, comprising up to 50% of 
all primary cardiac tumors (figure 1) (8). Myxomas occur with increased frequency in the 
third to sixth decades of life (9). Up to 90% occur in the left atrium where they are 
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usually attached to the atrial septum, in or adjacent to the fossa ovalis (10). The 
remainder occur in the right atrium or, infrequently, in the ventricles. They are more 
common in women, with a 2:1 female preponderance. Patients can present with systemic 
embolization (cerebral or peripheral) or with symptoms due to obstruction of the mitral 
valve. They will often have constitutional symptoms such as anemia, fever, and weight 
loss. Additionally, the erythrocyte sedimentation rate is often increased (5).  
 
“Syndrome myxoma” refers to one of several genetic disorders which should be 
suspected in patients younger than 40 years who present with multiple cardiac myxomas. 
These can include biatrial, ventricular and recurrent myxomas. These syndromes are 
typically associated with blue nevi, cutaneous lentiginosis, peripheral tumors and 
endocrine neoplasms. Myxoma syndromes include LAMB (lentigines, atrial myxomas, 
mucocutaneous myxomas, and blue nevi), NAME (nevi, atrial myxomas, myxoid 
neurofibroma, and ephelides and Carney syndrome (atrial, cutaneous and mammary 
myxomas, lentigines, blue nevi, endocrine disorders and testicular tumours)  
If  diagnosed, all first degree relatives should be screened for the condition (11,12).  
 
 
Structurally, most myxomas have a stalk, are gelatinous, and have a broad base. The 
surface may be friable or villous. There can be different consistencies within the 
myxoma, including areas that may be hemorrhagic or cystic (11,13). 
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The diagnosis of atrial myxoma by imaging requires prompt resection since there is a risk 
of embolization and sudden death. Surgical outcome is generally good, with a 20-year 
survival rate of 85%. However, there is a recurrence rate after resection of approximately 
5%. Therefore careful, serial follow-up is required (7). 
 
 
Papillary Fibroelastomas 
Papillary fibroelastomas are rare, comprising less than 10% of all primary cardiac tumors 
examined at autopsy or post resection (figure 2a, figure 2b, figure 3) (14).  They are the 
most common valvular tumor and the third most common primary cardiac tumor (after 
myxoma and fibroma). Papillary fibroelastomas have been referred to by various names, 
including myxofibroma, cardiac papilloma, papillary fibroma and giant Lambl’s 
excrescences. Giant Lambl's excrescences are caused by wear-and tear of valves, 
commonly the aortic valve, and comprise a densely hyalinized central core lined by 
endocardial-type spindle cells. Papillary fibroelastomas occur predominantly in males 
with a mean age at the time of detection of 60 years. Although the natural history of these 
tumors is not fully known, lesions have been observed to develop over periods ranging 
from 6 months to 15 years (15,16). In 90% of cases these tumors are found on cardiac 
valves. Other sites include the coronary sinus os, right ventricular endocardium, the left 
ventricular septum, and the both the right and left outflow tracts. Lesions usually occur 
on left-sided cardiac valves, with approximately 36% involving the aortic valve and 29% 
affecting the mitral valve (17,18). In one case series (19), where lesions were identified 
pathologically from surgical specimens, tumors tended to occur in areas of endocardial 
 7 
irritation, including degenerative aortic valve sclerosis, mitral valve prolapse, prior 
surgical repair of congenital ventriculoseptal defect, systolic anterior motion of mitral 
valve, and hypertrophic cardiomyopathy. Some lesions occur as congenital 
malformations, including a case of a 9-month-old child with a tricuspid valve tumor 
obstructing the right ventricular outflow tract, but most are acquired (20). 
 
The majority of papillary fibroelastomas are solitary with multiple tumors seen in <10% 
of patients. Most lesions are less than 20mm in their largest diameter. They have been 
described pathologically as having the appearance of sea anemones, with multiple 
papillary fronds arising from a central stalk (15,21). 
 
Papillary fibroelastomas are rarely cause valvular dysfunction. However, left-sided 
tumors can be associated with serious symptoms including angina, transient ischemic 
attacks and sudden death. While tumor embolization may be responsible for the central 
neurological events it is also possible that the tumors serve as a nidus for clot formation 
which may subsequently embolize (22,23). 
 
Echocardiographically, the distinguishing feature between papillary fibroelastoma and a 
Lambl’s excrescence is size, with fibroelastomas being larger. Myxomas can usually be 
distinguished from fibroelastomas based on location with the former usually attached to 
the atrial septum and the latter to a left sided valve (24). 
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The size of the lesion does not always correlate with the risk of developing serious 
morbidity and there may be no warning signs before a serious event. Surgical removal of 
lesions (in the absence of major surgical contraindications) may therefore be considered 
(25,26). 
 
Rhabdomyomas 
These lesions occur almost exclusively in children, in the majority before one year of age. 
They are the most common primary cardiac neoplasm in children. Rare cases have been 
reported in adults. These lesions are usually found on the ventricular walls or the 
atrioventricular valves (27). Microscopically lesions demonstrate striated muscle fibers 
with features typical of myocytes. Symptoms may result from arrhythmias or mechanical 
complications due to obstruction of blood flow in the heart. The majority of 
rhabdomyomas regress spontaneously (28). 
 
Fibromas 
Cardiac fibromas are the second most common pediatric cardiac tumors. They may also 
occur in adults. Fibromas usually arise in ventricular muscle. Histologically, they have 
features of fibroblasts and may give a false appearance of malignant myocardial 
infiltration due to encompassing areas of myocardium (28,29). Symptoms are due to 
conduction abnormalities, resulting in arrhythmias and sudden cardiac death, and 
mechanical obstruction of blood flow within the heart, which can lead to congestive heart 
failure. Unlike rhabdomyomas, fibromas do not regress on their own in children and 
often require resection (11). 
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Lipomas 
Lipomas comprise a benign accumulation of adipocytes. They may occur anywhere in the 
heart and can occur in the pericardium, subendocardium, subepicardium, and intra-atrial 
septum. Tumor size ranges from a few centimeters to many kilograms. Symptoms, when 
they occur, are due to arrhythmias and conduction block or may be related to anginal pain 
due to compression of coronary arteries (30,31). These tumors tend to progressively 
enlarge and, when symptomatic, need to be excised. 
 
Lipomatous septal hypertrophy 
Lipomatous septal hypertrophy is due to increased growth of adipocytes within the atrial 
septum. They occur only in the interatrial septum. Found mainly among elderly and 
obese patients it is not a true cardiac tumor (32). The accumulation of fat in the septum 
may result in atrial arrhythmias or atrio-ventricular conduction abnormalities. In the 
absence of these effects these no treatment is required (33). 
 
 
Malignant Cardiac Tumors 
Sarcomas 
Approximately 25% of primary cardiac tumors are malignant. The majority are sarcomas 
(Figure 4).  Sarcomas have variable presentations, depending more on tumor location 
than pathological type. This makes early diagnosis difficult. Patients may present with 
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vague symptoms such as dyspnea, or more dramatically with pulmonary hemorrhage or 
even cardiovascular collapse.  
 
Angiosarcomas 
Angiosarcomas occur most frequently in the adult population and are more common in 
males. They have a propensity to occur on the right side of the heart, especially the right 
atrium (34,35). Lesions may be large, replacing the atrial wall and extending into the 
chamber, even occasionally completely filling it. They can invade the vena cava, 
tricuspid valve and pericardium. Mesenchymal in origin they are composed of malignant 
cells forming vascular channels. Microscopically, a sinusoidal pattern is often seen. There 
are two clinicopathological forms of angiosarcoma.  In the first type tumor deposits 
involve the epicardium or pericardium, are usually small and asymptomatic, and are 
associated with skin lesions of or risk factors for Karposi’s sarcoma. The second type 
involves large symptomatic lesions, occurring in the right atrium, which are not 
associated with Karpoi’s sarcoma or its risk factors. Treatment with chemotherapy or 
radiation does not relieve symptoms as well as tumor resection, although survival data on 
surgically treated lesions in both types are rare (36). 
 
 
 Rhabdomyosarcomas  
Rhabdomyosarcoma is the second most common primary sarcoma. These tumors occur 
equally in both sexes and are multicentric in up to 60% of patients. Patients often present 
with non-specific symptoms. They may occur in any cardiac chamber, are bulky and 
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invasive, grow rapidly, and often have invaded pericardium by the time of diagnosis (37). 
Surgical resection of small tumors is often attempted, but due to local and distant 
metastasis, and poor response to radiation and chemotherapy, prognosis is poor (38). 
 
Leiomyosarcomas 
Primary leiomyosarcomas of the heart are extremely rare and comprise less than 0.25% 
of all primary cardiac tumors. They are usually found in the left atrium and histologic 
demonstrates spindle-shaped cells. Presenting symptoms result from arrhythmias, 
including sudden death, and hemopericardium (39). Patients may also present with 
symptoms due to obstruction which may mimic pulmonary thromboembolism or mitral 
valve stenosis. These tumors are highly aggressive, spread systemically, have early local 
resurrence, and are locally invasive. Resection is mainly palliative. Extensive resection 
followed by chemotherapy may improve prognosis (39,40). 
 
 
 
Imaging 
Diagnosis of intracardiac tumors is often possible by transthoracic echocardiography 
(TTE), with a detection rate of 95.2%. In cases where there is doubt or image quality is 
not optimal, transesophageal echocardiography (TEE) may be attempted. (41). Both CT 
scanning and cardiac MRI produce high resolution images of the heart. Both can provide 
additional information regarding extent of tumor within the heart or into adjacent 
extracardiac structures, and may help in making histologic distinctions. Contrast 
 12 
enhancement can be used to differentiate tumors from thrombi since thrombi do not 
usually show enhancement and fat-suppression techniques may further define tumors 
such as lipomas (42). Finally, these techniques provide good definition of lesions prior to 
any surgical interventions.  
 
 
Conclusion 
Primary cardiac tumors are rare with three-quarters being benign (mostly myxomas). The 
remaining 25% are malignant, mainly sarcomas. Diagnosis often requires a high index of 
suspicion as presentations can be variable. Signs and symptoms can include new onset 
dyspnea, congestive heart failure, arrhythmias or murmurs varying with body positions. 
Echocardiography remains the cornerstone of diagnosis but cardiac CT and MRI can 
often provide additional useful information. Surgical resection is the primary treatment 
modality, with radiotherapy and chemotherapy being largely palliative.  
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Figure 1 
Sixty-four year old man who presented with vague neurologic symptoms. Transthoracic 
echo revealed a left atrial mass at the junction of the atrial septum and anterior mitral 
leaflet prompting this transesophageal echocardiogram. Surgical resection demonstrated a 
myxoma. 
 
Figure 2a 
In-situ operative field view of left atrial appendage showing attached mass which was 
histologically diagnosed as papillary fibroelastoma. 
 
Figure 2b 
Histological preparation of papillary fibroelastoma showing avascular papillary structures 
lined with endothelial cells. 
 
Figure 3 
Intra-operative image of atrioventricular papillary fibroelastoma. 
 
Figure 4 
Thirty-five year old woman who presented with dyspnea. Transthoracic echocardiogram 
showed a large irregular left atrial mass prompting this transesophageal echocardiogram. 
Surgical resection demonstrated a myxofibrosarcoma. 
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